U.S. Interactive Media and Services Stock News

NYSE:FCPT
NYSE:FCPTSpecialized REITs

Four Corners Property Trust FFO Supports Income Narrative Despite Valuation Premium Concerns

Four Corners Property Trust (FCPT) has wrapped up FY 2025 with fourth quarter total revenue of US$75.7 million, basic EPS of US$0.28 and funds from operations of US$45.7 million, giving investors a fresh look at the REIT's cash generation. Over the past six quarters, the company has seen total revenue move from US$66.8 million in Q3 2024 to US$75.7 million in Q4 2025. Trailing twelve month revenue sits at US$294.1 million and EPS at US$1.09, framing the latest results for income-focused...
NYSE:WMB
NYSE:WMBOil and Gas

Williams Companies Growth Projects And Partnership Shift Valuation And Dividend Picture

Williams Companies (NYSE:WMB) has completed a series of major pipeline and offshore projects and formed a new partnership with Woodside Energy. The company has launched ten new initiatives across pipeline transmission, gathering, storage, and power-related projects. Williams has sold its Haynesville E&P business and outlined substantial new growth capital commitments. The company has also announced a 5% dividend increase alongside its latest expansion plans. For investors watching NYSE:WMB,...
NasdaqCM:MVBF
NasdaqCM:MVBFBanks

MVB Financial (MVBF) Margin Stability Questioned As Q4 Cost Ratios Challenge Bullish Narratives

MVB Financial (MVBF) has wrapped up FY 2025 with fourth quarter revenue of US$36.9 million and basic EPS of US$0.33, set against trailing twelve month revenue of US$158.9 million and EPS of US$2.11 that frame the full year earnings picture. Over recent periods, the company has seen quarterly revenue move between US$31.7 million and US$56.8 million, while basic EPS has ranged from US$0.16 to US$1.36, giving investors a wide band of outcomes to weigh as they assess the latest print. With a...
NYSE:BIO
NYSE:BIOLife Sciences

Bio Rad Laboratories Q3 Loss Of US$12.70 EPS Tests Recovery Narrative For BIO Stock

Bio-Rad Laboratories (BIO) has put up a mixed set of numbers for Q3 FY 2025, with revenue of US$653 million and a basic EPS loss of US$12.70, against a backdrop of prior quarters that ranged from EPS of US$23.37 on US$649.7 million of revenue in Q3 FY 2024 to a loss of US$25.57 on US$667.48 million of revenue in Q4 FY 2024. Over the past few quarters, revenue has generally sat in the US$585 million to US$667 million band, while EPS has swung sharply between gains and losses. Investors will...
NYSE:TWLO
NYSE:TWLOIT

Twilio (TWLO) Q4 EPS Loss Challenges Profitability‑Focused Bull Narrative

Twilio (TWLO) closed FY 2025 with fourth quarter revenue of US$1.37b and basic EPS of a US$0.30 loss, as net income excluding extra items came in at a loss of US$45.85m. Across the year, the company has seen quarterly revenue move from US$1.17b in Q1 to US$1.37b in Q4. Basic EPS ranged from US$0.13 in Q1 to US$0.24 in Q3, before swinging back to a loss in the final quarter. This sets up a mixed but margin-focused story for investors to unpack. See our full analysis for Twilio. With the...
NYSE:EPRT
NYSE:EPRTREITs

Essential Properties Realty Trust (EPRT) FFO Growth Reinforces Predictable Income Narrative

Essential Properties Realty Trust (EPRT) just posted its FY 2025 numbers with fourth quarter revenue of US$149.9 million, basic EPS of US$0.34 and funds from operations of US$108.9 million, giving investors a fresh read on its income producing portfolio. The company has seen quarterly revenue move from US$119.7 million in Q4 2024 to US$149.9 million in Q4 2025, while basic EPS went from US$0.31 to US$0.34 over the same period, with FFO per share stepping from US$0.49 in Q3 2024 to US$0.54 in...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Himax Technologies (HIMX) Margin Compression Challenges Bullish Earnings Growth Narrative

Himax Technologies (HIMX) closed FY 2025 with fourth quarter revenue of US$203.1 million and basic EPS of US$0.07, alongside net income of US$6.3 million, setting a clear marker for how the year wrapped up. Over recent periods the company has seen quarterly revenue move from US$237.2 million and EPS of US$0.14 in Q4 2024 to US$215.1 million and EPS of US$0.11 in Q1 2025, US$214.8 million and EPS of US$0.09 in Q2, and US$199.2 million and EPS of US$0.01 in Q3, before landing at the latest Q4...
NasdaqCM:FMAO
NasdaqCM:FMAOBanks

Farmers & Merchants Bancorp (FMAO) Net Interest Margin Expansion Reinforces Bullish Narratives

Farmers & Merchants Bancorp (FMAO) has wrapped up FY 2025 with fourth quarter revenue of US$31.9 million and EPS of US$0.71, capping off a trailing twelve month run of US$119.4 million in revenue and EPS of US$2.39 alongside 29.8% earnings growth over the past year. Over recent periods the company has seen revenue move from US$26.6 million and EPS of US$0.59 in Q4 2024 to US$31.9 million and EPS of US$0.71 in Q4 2025, while trailing net income has reached US$33.0 million. With net profit...
NYSE:YELP
NYSE:YELPInteractive Media and Services

Yelp (YELP) Margin Improvement Reinforces Bullish Profitability Narratives Despite Slower Growth Forecasts

Yelp FY 2025 earnings snapshot Yelp (YELP) closed FY 2025 with fourth quarter revenue of US$360.0 million and basic EPS of US$0.62, alongside net income of US$37.8 million, setting the tone for a year in which trailing twelve month revenue reached about US$1.5 billion and EPS came in at US$2.30. Over the past six quarters, the company has seen quarterly revenue move between US$358.5 million and US$376.0 million, while basic EPS ranged from US$0.37 to US$0.69, giving you a clear line of sight...
NYSE:AAP
NYSE:AAPSpecialty Retail

Advance Auto Parts (AAP) Same Store Sales Rebound Tests Profitability Turnaround Narratives

Latest earnings snapshot and why it matters for the AAP story Advance Auto Parts (AAP) just posted third quarter FY 2025 revenue of about US$2.0 billion with basic EPS near breakeven at roughly US$0.02 loss, setting a cautious tone after a run of mixed results. The company has seen quarterly revenue move from US$2.18 billion in the second quarter of FY 2024 to US$2.58 billion in the first quarter of FY 2025, while basic EPS has swung from a US$10.20 loss in the fourth quarter of FY 2024 to a...
NYSE:WPC
NYSE:WPCREITs

W. P. Carey’s €1b Notes Reshape Debt Profile And Portfolio Mix

W. P. Carey (NYSE:WPC) has completed a €1b senior unsecured note offering. The euro denominated notes are intended to help manage existing debt and fund new investments. The company is reshaping its portfolio, including acquisitions, property sales, and an exit from self storage and office assets. W. P. Carey runs a diversified net lease real estate portfolio, where tenants typically handle many property level costs. The latest financing move comes as the company adjusts its mix of...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar Holdings (PLMR) Earnings Surge 67.6% And Reinforce Bullish Profitability Narratives

Palomar Holdings FY 2025 earnings snapshot Palomar Holdings (PLMR) has capped FY 2025 with fourth quarter revenue of US$253.4 million and basic EPS of US$2.12, rounding out a year in which trailing twelve month revenue reached US$876.0 million and EPS came in at US$7.40 on net income of US$197.1 million. Over the past few quarters the company has seen revenue move from US$174.6 million and EPS of US$1.61 in Q1 2025 to US$253.4 million and EPS of US$2.12 in Q4, with Q3 sitting at US$244.7...
NYSE:PDM
NYSE:PDMOffice REITs

Piedmont Realty Trust Q4 FFO Drop Tests Bullish Cash Flow Narratives

Piedmont Realty Trust FY 2025 earnings snapshot Piedmont Realty Trust (PDM) has just posted its FY 2025 numbers, with fourth quarter revenue of US$142.9 million and basic EPS of a US$0.35 loss, alongside funds from operations of US$14.4 million. Over recent quarters the company has seen revenue move between US$139.2 million and US$143.2 million, while basic EPS has ranged from a US$0.08 loss to a US$0.35 loss. This gives a clear view of how the top line and per share results have tracked into...
NasdaqGS:CRSR
NasdaqGS:CRSRTech

Corsair Gaming (CRSR) Valuation Check After Earnings, 2026 Guidance And New Share Buyback

What Corsair just told the market Corsair Gaming (CRSR) has packed a lot into its latest update, combining Q4 and full year 2025 results with fresh 2026 guidance and a new US$50 million share buyback plan. For Q4 2025, Corsair reported sales of US$436.86 million and net income of US$25.79 million, with basic earnings per share from continuing operations at US$0.23 and diluted earnings per share at US$0.22. Across 2025 as a whole, sales were US$1.47 billion, while the company recorded a net...
NYSE:GNRC
NYSE:GNRCElectrical

Generac Holdings Q4 Loss And Margin Compression Test High P/E Growth Narrative

Generac Holdings (GNRC) closed out FY 2025 with Q4 revenue of US$1.1b and a basic EPS loss of US$0.42, as net income excluding extra items came in at a loss of US$24.5m, setting a cautious tone around profitability. The company has seen quarterly revenue move from US$1.23b in Q4 2024 to US$1.1b in Q4 2025, while basic EPS shifted from US$2.18 a year ago to a loss of US$0.42, and trailing 12 month EPS eased from US$5.46 in Q4 2024 to US$2.73 in Q4 2025, which leaves investors weighing softer...
NYSE:BAP
NYSE:BAPBanks

Credicorp’s Mibanco SaaS Upgrade With Temenos And What It Signals For Valuation

Mibanco, the microfinance arm of Credicorp (NYSE:BAP), is partnering with Temenos to modernize its core banking platform using software as a service. The collaboration focuses on faster product launches, improved customer experience, and broader financial inclusion for small businesses in Peru. For Credicorp, which has a strong presence in microfinance through Mibanco, this tech upgrade relates directly to how banking services are delivered to small and midsize enterprises in Peru. The move...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Reassessing Omnicell (OMCL) After Sharp Multi‑Year Share Price Declines

If you are wondering whether Omnicell's current share price really reflects its potential, this article will walk through how the stock stacks up on value. The shares most recently closed at US$36.18, after returns of a 7.4% decline over 7 days, 29.6% decline over 30 days, 19.8% decline year to date, 10.1% decline over 1 year, 33.5% decline over 3 years, and 72.1% decline over 5 years. Recent news coverage around Omnicell has focused on the company as part of broader discussions about...
NasdaqGS:CFLT
NasdaqGS:CFLTSoftware

Confluent (CFLT) Revenue Growth Versus Persistent Losses Tests High Multiple Narratives

Confluent (CFLT) just wrapped up FY 2025 with Q4 revenue of US$314.8 million and a basic EPS loss of US$0.23, while trailing twelve month revenue sat at about US$1.17 billion against a full year basic EPS loss of US$0.86. Over recent quarters, the company has seen revenue move from US$261.2 million in Q4 2024 to US$314.8 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.19 and US$0.27. The latest print keeps the spotlight firmly on how quickly revenue growth can offset...
NYSE:PMT
NYSE:PMTMortgage REITs

Is PennyMac Mortgage Investment Trust (PMT) Pricing Look Stretched After Recent Share Price Weakness

If you are wondering whether PennyMac Mortgage Investment Trust is offering good value at its recent share price, you are not alone. This article is designed to help you make sense of that question. The stock most recently closed at US$12.49, with returns of 2.0% over the past week, a 5.2% decline over the past month, a 1.3% decline year to date, and a 3.4% return over the last year, alongside cumulative returns of 26.2% over three years and 22.1% over five years. Recent coverage has focused...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Sarepta’s SRP-1005 Trial Approval Opens New Huntington’s Disease Opportunity

Sarepta Therapeutics (NasdaqGS:SRPT) received Medsafe approval in New Zealand for its first-in-human clinical trial of SRP-1005. SRP-1005 is an investigational siRNA therapeutic targeting Huntington's Disease, a severe neurodegenerative condition. The authorization allows Sarepta to begin a Phase 1 study, marking its clinical entry into Huntington's Disease research. Sarepta Therapeutics is best known for its Duchenne muscular dystrophy franchise, and SRP-1005 broadens its rare disease...
NYSE:CNR
NYSE:CNROil and Gas

Core Natural Resources (CNR) Returns To Quarterly Profit Challenging Bearish Narratives On Coal Risks

Core Natural Resources (CNR) has posted a mixed set of FY 2025 numbers, with Q3 revenue at about US$1.0 billion and basic EPS of US$0.61 alongside a trailing twelve month loss of US$43.4 million on basic EPS of US$0.94. The company has seen quarterly revenue move from US$553.4 million in Q3 2024 to more than US$1.0 billion in Q3 2025, while basic EPS has swung between a profit of US$3.23 and a loss of US$1.38 over that stretch. This highlights how volatile margins have been. For investors,...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Mixed Returns And A 13.9% Undervaluation Narrative

What is moving Amphastar Pharmaceuticals now? Amphastar Pharmaceuticals (AMPH) has drawn investor attention after its recent share performance, with the stock around $27.55 and short term returns mixed between the past week, month and past 3 months. See our latest analysis for Amphastar Pharmaceuticals. At around $27.55, Amphastar Pharmaceuticals has given investors a mixed ride, with recent share price returns over the past week and month soft, while the 90 day share price return of 5.72%...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Is Kodiak AI (KDK) Starting To Look Interesting After Recent Share Price Weakness?

If you are wondering whether Kodiak AI at around US$8.35 is starting to look interesting on price alone, it helps to step back and look at what the current market is implying about its value. Over the short term, the stock has been under pressure, with a 7 day return of 4.4% decline, a 30 day return of 11.1% decline, and a year to date return of 22.9% decline, contributing to a 24.4% decline over the past year. This weaker share price backdrop is unfolding alongside broader evergreen...